| Dr Rachel H Inker, MD | |
|
617 Riverside Ave, Burlington, VT 05401-1601 | |
| (802) 864-6309 | |
| (802) 860-4324 |
| Full Name | Dr Rachel H Inker |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 617 Riverside Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558347096 | NPI | - | NPPES |
| 3857011 | Other | CIGNA HEALTH CARE | |
| VN2612 | Other | TRICARE | |
| 58929 | Other | VT | BLUE CROSS BLUE SHIELD |
| 58929 | Other | VT | VERMONT MANAGED CARE |
| OVN2612 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0420010020 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Colorectal cancer is the second leading cause of cancer deaths, according to background information in the article. Screening asymptomatic patients is an important strategy for reducing these deaths, because by the time patients experience symptoms, the cancer may have progressed beyond the point where it can be cured.
With the help of BMC Software, Blue Cross and Blue Shield of Florida (BCBSF) is reducing costs while preparing for the new demands healthcare reform will bring to IT.
Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.
Beneficial bacteria on the skin of lab mice work with the animals' immune systems to defend against disease-causing microbes and accelerate wound healing, according to new research from scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
› Verified 7 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Colorectal cancer is the second leading cause of cancer deaths, according to background information in the article. Screening asymptomatic patients is an important strategy for reducing these deaths, because by the time patients experience symptoms, the cancer may have progressed beyond the point where it can be cured.
With the help of BMC Software, Blue Cross and Blue Shield of Florida (BCBSF) is reducing costs while preparing for the new demands healthcare reform will bring to IT.
Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.
Beneficial bacteria on the skin of lab mice work with the animals' immune systems to defend against disease-causing microbes and accelerate wound healing, according to new research from scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
› Verified 7 days ago
| Entity Name | Community Health Centers Of Burlington Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689678963 PECOS PAC ID: 2062491251 Enrollment ID: O20040720000792 |
News Archive
Colorectal cancer is the second leading cause of cancer deaths, according to background information in the article. Screening asymptomatic patients is an important strategy for reducing these deaths, because by the time patients experience symptoms, the cancer may have progressed beyond the point where it can be cured.
With the help of BMC Software, Blue Cross and Blue Shield of Florida (BCBSF) is reducing costs while preparing for the new demands healthcare reform will bring to IT.
Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.
Beneficial bacteria on the skin of lab mice work with the animals' immune systems to defend against disease-causing microbes and accelerate wound healing, according to new research from scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
› Verified 7 days ago
| Entity Name | Northwestern Occupational Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578650099 PECOS PAC ID: 4789742685 Enrollment ID: O20081022000067 |
News Archive
Colorectal cancer is the second leading cause of cancer deaths, according to background information in the article. Screening asymptomatic patients is an important strategy for reducing these deaths, because by the time patients experience symptoms, the cancer may have progressed beyond the point where it can be cured.
With the help of BMC Software, Blue Cross and Blue Shield of Florida (BCBSF) is reducing costs while preparing for the new demands healthcare reform will bring to IT.
Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.
Beneficial bacteria on the skin of lab mice work with the animals' immune systems to defend against disease-causing microbes and accelerate wound healing, according to new research from scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rachel H Inker, MD 493 S Union St, Burlington, VT 05401-4805 Ph: (802) 864-6309 | Dr Rachel H Inker, MD 617 Riverside Ave, Burlington, VT 05401-1601 Ph: (802) 864-6309 |
News Archive
Colorectal cancer is the second leading cause of cancer deaths, according to background information in the article. Screening asymptomatic patients is an important strategy for reducing these deaths, because by the time patients experience symptoms, the cancer may have progressed beyond the point where it can be cured.
With the help of BMC Software, Blue Cross and Blue Shield of Florida (BCBSF) is reducing costs while preparing for the new demands healthcare reform will bring to IT.
Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.
Beneficial bacteria on the skin of lab mice work with the animals' immune systems to defend against disease-causing microbes and accelerate wound healing, according to new research from scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
› Verified 7 days ago
Dr. Adam Greenlee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 Fax: 802-860-4313 | |
Dr. Patricia L Fisher, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 Fax: 802-860-4324 | |
Robert E Gramling, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Uvm Medical Center - Palliative Care Services, Burlington, VT 05401 Phone: 802-847-4848 Fax: 802-847-2929 | |
Dr. Jon Kevin Porter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 Pearl St, Burlington, VT 05401 Phone: 802-656-3350 Fax: 802-656-8178 | |
Robert A Penney, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 789 Pine St, Burlington, VT 05401 Phone: 802-864-0693 Fax: 802-860-6613 | |
David A Reisman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Dr. Katherine M Mariani, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Timber Lane, Uvm Medical Center-adult Primary Care, S. Burlington, Burlington, VT 05401 Phone: 802-847-8500 Fax: 802-847-6140 |